Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Johnston

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Mental Health Today (Brighton, England)|May 19, 2005
This lifeJean Johnston
Orphanet Journal of Rare Diseases|August 5, 2020
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)Elin Haf Davies, Jean Johnston, Camilo Toro, et al.
The British Journal of Ophthalmology|August 6, 2020
A sialidosis type I cohort and a quantitative approach to multimodal ophthalmic imaging of the macular cherry-red spotMalena Daich Varela, Wadih M Zein, Camilo Toro, et al.
American Journal of Medical Genetics. Part A|December 10, 2015
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosisDebra S Regier, Hyuk Joon Kwon, Jean Johnston, et al.
Frontiers in Neuroimaging|October 1, 2024
Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patientsChristopher Zoppo, Josephine Kolstad, Jean Johnston, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective StudyPrecilla D'Souza, Cristan Farmer, Jean Johnston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2017
Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline ModelHeather L Gray-Edwards, Debra S Regier, Jamie L Shirley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Mental Health Today (Brighton, England)|May 19, 2005
This lifeJean Johnston
Orphanet Journal of Rare Diseases|August 5, 2020
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease)Elin Haf Davies, Jean Johnston, Camilo Toro, et al.
The British Journal of Ophthalmology|August 6, 2020
A sialidosis type I cohort and a quantitative approach to multimodal ophthalmic imaging of the macular cherry-red spotMalena Daich Varela, Wadih M Zein, Camilo Toro, et al.
American Journal of Medical Genetics. Part A|December 10, 2015
MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosisDebra S Regier, Hyuk Joon Kwon, Jean Johnston, et al.
Frontiers in Neuroimaging|October 1, 2024
Quantitative reliability assessment of brain MRI volumetric measurements in type II GM1 gangliosidosis patientsChristopher Zoppo, Josephine Kolstad, Jean Johnston, et al.
Medrxiv : the Preprint Server for Health Sciences|February 5, 2024
GM1 Gangliosidosis Type II: Results of a 10-Year Prospective StudyPrecilla D'Souza, Cristan Farmer, Jean Johnston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 26, 2017
Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline ModelHeather L Gray-Edwards, Debra S Regier, Jamie L Shirley, et al.
Pageof 1